<- Go Home
SofWave Medical Ltd.
SofWave Medical Ltd. engages in the development, production, marketing, and distribution of non-invasive medical technology for skin firming and rejuvenation, tissue renewal, treatment of muscle, aging, and other physiological change in Israel, the United States, Europe, Southeast Asia, the Middle East, and internationally. The company offers an ultrasound technology that induces coagulation and subsequent revitalization for regenerated skin under the SUPERB brand; and non-invasive muscle toning technology under the Pure Impact VIP brand. It serves plastic surgeons, dermatologists, and other physicians who perform aesthetic treatments on patients. It also provides technical and clinical product support services. The company was incorporated in 2015 and is based in Yokneam Illit, Israel.
Market Cap
ILS 422.3M
Volume
64.4K
Cash and Equivalents
ILS 28.2M
EBITDA
ILS 11.4M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
ILS 78.6M
Profit Margin
75.33%
52 Week High
ILS 16.26
52 Week Low
ILS 8.07
Dividend
N/A
Price / Book Value
11.13
Price / Earnings
53.21
Price / Tangible Book Value
11.13
Enterprise Value
ILS 385.4M
Enterprise Value / EBITDA
31.58
Operating Income
ILS 10.1M
Return on Equity
27.42%
Return on Assets
11.83
Cash and Short Term Investments
ILS 38.3M
Debt
ILS 1.4M
Equity
ILS 38.0M
Revenue
ILS 104.3M
Unlevered FCF
ILS 13.0M
Sector
Health Care Equipment and Supplies
Category
N/A